Jun 27, 2026
15 MIN READ

Wegovy Starter Dose: Your First Steps to Sustainable Weight Management

Starting semaglutide requires a carefully calibrated approach to minimize side effects while building tolerance. PlexusDx offers personalized semaglutide injection therapy beginning at $149 per month with no insurance required.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 27, 2026
15 MIN READ

wegovy starter dose: your first steps to sustainable weight management — PlexusDx GLP-1 education

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing gastric emptying and signaling fullness to your brain's appetite centers, but the initial dose matters significantly for treatment success. Most patients begin with a 0.25 mg weekly injection and follow a gradual titration schedule over 16 weeks. PlexusDx provides compounded semaglutide injections from licensed 503A pharmacies, starting at $149 per month, allowing you to begin your weight management journey without insurance barriers.

How Semaglutide Starter Doses Build Tolerance

The standard semaglutide titration protocol starts at 0.25 mg weekly to let your body adapt to the medication's effects. During week one through four, this low dose activates GLP-1 receptors in your digestive system without overwhelming your system. Most patients experience minimal nausea at this entry point, making it easier to continue treatment and reach therapeutic benefit.

Over the following 12 weeks, doses typically increase in 0.25 mg increments at four-week intervals: 0.5 mg in weeks 5–8, 0.75 mg in weeks 9–12, and 1.0 mg in weeks 13–16. This gradual progression allows your body to develop tolerance while maximizing appetite suppression as you advance. Each step-up occurs only after your system demonstrates readiness, reducing the likelihood of treatment discontinuation due to side effects.

Understanding Your First Semaglutide Injection

Your initial 0.25 mg semaglutide injection takes effect within hours, signaling your pancreas to release insulin in response to glucose and triggering satiety signals in your hypothalamus. Most patients notice reduced hunger within 24–48 hours of the first dose, though appetite suppression gradually intensifies over the first four weeks. Some individuals experience mild nausea, constipation, or reduced food enjoyment during this adaptation phase, which typically resolves as your body acclimates.

PlexusDx compounded semaglutide injections come in prefilled pens designed for once-weekly subcutaneous administration on the same day each week. You'll inject into your abdomen, thigh, or upper arm—rotating injection sites minimizes lipodystrophy and ensures consistent absorption. Starting this protocol without insurance coverage is now accessible through PlexusDx at $149 per month, eliminating the need for pharmacy chains or prior authorization delays.

Side Effects During the Starter Phase

Gastrointestinal effects represent the most common experience in the first four weeks: nausea affects 20–30% of patients on starter doses, while constipation and reduced appetite drive the medication's therapeutic effect. These symptoms typically peak during the first injection and decrease significantly by week three as your digestive system adapts. Drinking adequate water, eating smaller meals, and maintaining fiber intake help manage these temporary adjustments without requiring dose reduction.

Serious adverse events during the starter phase remain rare in clinical populations without personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. Most patients tolerate 0.25 mg without systemic complications, though individual variation exists. If nausea persists beyond two weeks or worsens with continued dosing, contact your PlexusDx provider immediately—dose timing or injection technique may require adjustment.

Personalized Dosing Strategy at PlexusDx

PlexusDx offers the optional Precision Peptide Genetic Test ($99 add-on after your first month) to identify your genetic predispositions across GLP-1 receptor sensitivity, appetite regulation pathways, and metabolic capacity. Testing evaluates key variants including GLP1R rs6923761 and GIPR rs1800437, which influence how efficiently your body responds to semaglutide's signaling. This genetic insight allows your PlexusDx provider to personalize your titration schedule and target dose, potentially accelerating results while minimizing side effects.

Your dose may need to go up as you progress through the 16-week protocol, but your price won't—PlexusDx maintains flat monthly pricing at $149 across all therapeutic semaglutide dose levels. This pricing model removes the financial barrier to optimal dosing, ensuring you reach your target dose based on clinical need rather than cost constraints. HSA and FSA accounts cover PlexusDx semaglutide, and all 50 states are served with no membership fees.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What should I eat during my first week of semaglutide?

Focus on small, protein-rich meals and stay hydrated to support tolerance during the starter dose phase. Avoid high-fat and high-sugar foods, which may trigger nausea; instead choose lean proteins, vegetables, and whole grains in reduced portions. PlexusDx providers can share detailed nutrition guidance aligned with your individual GLP-1 response profile if you complete the Precision Peptide Genetic Test.

How much weight do patients lose on semaglutide starter doses?

Clinical trials show that after 16 weeks on the standard titration protocol, patients lose an average of 4–6 pounds during the starter phase alone, with significantly greater losses accumulating as maintenance doses take effect. Weight loss acceleration occurs weeks 5–8 when doses reach 0.5 mg, and continues through therapeutic completion. Individual results vary based on baseline weight, adherence, diet, and genetic factors evaluated in PlexusDx's Precision Peptide testing.

Can I start semaglutide at a higher dose to see faster results?

Starting above 0.25 mg significantly increases nausea, vomiting, and gastrointestinal distress, leading to higher discontinuation rates without improving long-term outcomes. The 0.25 mg starter protocol is evidence-based to optimize tolerance while building toward therapeutic benefit—rushing past this phase rarely accelerates results and often derails treatment. Your PlexusDx provider will recommend dose escalation timing based on your tolerance and clinical response.

Is PlexusDx semaglutide safe compared to Wegovy?

PlexusDx delivers compounded semaglutide from licensed 503A pharmacies, which operate under the same FDA regulatory standards as brand-name medications. Compounded semaglutide contains the identical active pharmaceutical ingredient as Wegovy, with safety determined by proper storage, sterility, and clinical supervision—not by brand name. PlexusDx providers monitor your response and adjust protocols based on individual tolerance, ensuring safe progression through your starter dose and beyond.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

The Precision Peptide Genetic Test examines your genetic variants across 14 pathways and 49 peptides relevant to weight regulation and GLP-1 response, including GIPR rs1800437 and GLP1R rs6923761. PlexusDx maps your unique peptide-pathway profile to predict how quickly you'll tolerate dose increases and which maintenance dose will deliver optimal appetite suppression. This personalization, available after your first month at $99, transforms your starter protocol from standard to precision-guided.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves